|
인쇄하기
취소
|
Bio-equivalency tested drug promptly to review its NHI price.
Published: 2002-09-26 06:58:00
Updated: 2002-09-26 06:58:00
The MOHW instructed to the Health Insurance Review Agency (HIRA) recently that the national health insurance (NHI) price authorization should be made far quickly for the drug of which its bio-equivalency test was completed and passed,
In the past the price review for such bio-equivalent test drugs used to take about 150 days as did with the new drug, but now the approval seems to be far sh...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.